What the public knows and wants to know about medicines research and development: A survey of the general public in six European countries

BMJ Open

Volumn 5, Issue 4, 2015, Pages

  Parsons, Suzanne ^a   Starling, Bella ^a   Mullan Jensen, Christine ^b   Tham, Su Gwan ^c   Warner, Kay ^d   Wever, Kim ^e  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; EUROPEAN; FEMALE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; KNOWLEDGE; LEARNING; MALE; MEDICAL RESEARCH; MIDDLE AGED; PRODUCT SAFETY; PROGRAM DEVELOPMENT; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; QUOTA SAMPLE; YOUNG ADULT; AGE; ATTITUDE TO HEALTH; DRUG DEVELOPMENT; EUROPE; PUBLIC OPINION; SEX DIFFERENCE;

ADULT; AGE FACTORS; AWARENESS; BIOMEDICAL RESEARCH; DRUG DISCOVERY; EUROPE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PUBLIC OPINION; SEX FACTORS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84929378799     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006420     Document Type: Article

References (30)

1. Coulter A. Patient engagement - what works? J Ambul Care Manage 2012;35:80-9.
2. Coulter A, Askham J, Parsons S. Where are the patients in decision making about their own care. WHO Regional Office for Europe, 2008:1-14.
3. Boote J, Wong R, Booth A. Talking the talk or walking the walk? A bibliometric review of the literature on public involvement in health research published between 1995 and 2009. Health Expect 2012;18:44-57.
4. Grogan K. Pharma optimistic about future, worried about reputation. Pharma Times online. http://www.pharmatimes.com/mobile/14-06-13/pharma-optimistic-about-future-worried-about-reputation.aspx?r=1 (13 June 2014) (accessed 8 Dec 2014).
5. Smits E, Boon W. The role of users in innovation in the pharmaceutical industry. Drug Discov Today 2008;13;353-9.
6. Harrison C. Patent watch - dangling from the patent cliff. Nat Rev Drug Discov 2013;12:14-15.
7. Moors E, Cohen AF, Schellekens H. Towards a sustainable system of drug development. Drug Discov Today 2014;19:1711-20.
8. Patient Partner website-http://www.patientpartner-europe.eu/en/home (accessed 5 Dec 2014).
9. Hemminki E, Toiviainen HK, Vuorenkoshi L. Co-operation between patient organisations and the drug industry in Finland. Soc Sci Med 2010;70;1171-5.
10. Ipsos public affairs. Reputation snapshot for the pharmaceutical sector. Ipsos Mori, 2012. http://www.ipsos.com/public-affairs/sites/www.ipsos.com.public-affairs/files/Pharma%20Reputation%20Snapshot%20-%20INTL.pdf (accessed 8 Dec 2014).
11. PricewaterhouseCoopers' Health Research Institute. Recapturing the vision - restoring trust in the pharmaceutical industry by translating expectations into action. PricewaterhouseCoopers, 2006. http://www.pwc.com/en-GX/gx/pharma-life-sciences/pdf/recapturing-the-vision-exsummary-final.pdf (accessed 8 Dec 2014).
12. Mansell P. Survey finds low awareness of clinical research as core NHS activity. 22-5-2012. http://www.pharmatimes.com/Article/12-05-22/Survey-finds-low-awareness-of-clinical-research-as-core-NHS-activity.aspx (accessed 8 Dec 2014).
13. Welcome Trust. Medical research and the public - Welcome Trust monitor findings. Welcome Trust, 2013. http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh-grants/documents/web-document/wtp052592.pdf (accessed 8 Dec 2014).
14. Patients academy website. http://www.patientsacademy.eu (accessed 8 Dec 2014).
15. Eurobarometer. Europeans and their languages. Brussels: European Commission, 2012. http://ec.europa.eu/public-opinion/archives/ebs/ebs-386-en.pdf (accessed 8 Dec 2014).
16. ICM research website. http://www.icmresearch.com (accessed 8 Dec 2014).
17. Willis GB. Cognitive interviewing: a tool for improving questionnaire design. London: Sage, 2005.
18. Bland JM. Statistic's notes@ Cronbach's alpha. BMJ 1997;314:572.
19. Jeremic V, Bulajic M, Martic M, et al. An evaluation of European countries' health systems through distance based analysis. Hippokratia 2012;16:170-4.
20. Radojicic Z, Jeremic V. Quantity or quality: what matters more in ranking higher education institutions. Curr Sci 2012;103:158-62.
21. Age profiles of European countries - Eurostat website. epp.eurostat.ec.europa.eu/portal/page/portal/statistics/search-database (accessed 8 Dec 2014).
22. Science media centre - evidence to select committee on clinical trials. http://www.sciencemediacentre.org/wp-content/uploads/2014/03/SMC-Evidence-on-clinical-trials.pdf (accessed 8 Dec 2014).
23. MHRA's webpage on increasing patients and the public's knowledge of regulation. http://www.mhra.gov.uk/safetyinformation/Generalsafetyinformationandadvice/Adviceandinformationforconsumers/Mymedicinefromlaboratorytopharmacyshelf/index.htm (accessed 8 Dec 2014).
24. Leroy T, Christophe V, Penel N, et al. Factual understanding of randomised clinical trials: a multi-center case control study in cancer patients. Invest New Drugs 2011;29:700-5.
25. Patient involvement in drug development - from theory to reality. http://www.patientsacademy.eu/index.php/en/news/press-area/pressreleases/361-patient-involvement-in-industry-r-d-from-theory-toreality (accessed 9 Dec 2014).
26. Kim AM, Tingen C, Woodruff T. Sex bias in trials and treatments must end. Nature 2012;465:668-9.
27. Bartlam B, Crome P, Lally F, et al. The views of older people and carers on participation in clinical trials: the PREDICT Study. J Clin Invest 2012;2:327-36.
28. Jolie A. My medical choice. http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html?-r=0 (accessed 9 Dec 2014).
29. Wang K, Hunt K, Nazareth I, et al. Do men consult less than women? An analysis of routinely collected UK general practice data. BMJ Open 2013;3:e003320.
30. Internet World Stats: European Internet Usage Statistics. Internet World Stats 2014 June. http://www.internetworldstats.com/stats4.htm (accessed 8 Dec 2014).